
Barry Choobin
Examiner (ID: 2847)
| Most Active Art Unit | 2625 |
| Art Unit(s) | 2623, 2721, 2621, 2624, 2625 |
| Total Applications | 321 |
| Issued Applications | 267 |
| Pending Applications | 27 |
| Abandoned Applications | 27 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18051606
[patent_doc_number] => 11524977
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-13
[patent_title] => Ultrasound-assisted simulated digestion method of milk protein active peptide and application thereof in health foods
[patent_app_type] => utility
[patent_app_number] => 16/632546
[patent_app_country] => US
[patent_app_date] => 2018-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9072
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632546 | Ultrasound-assisted simulated digestion method of milk protein active peptide and application thereof in health foods | Nov 11, 2018 | Issued |
Array
(
[id] => 14016189
[patent_doc_number] => 20190070088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => SILK PROTEIN FRAGMENT COMPOSITIONS AND ARTICLES MANUFACTURED THEREFROM
[patent_app_type] => utility
[patent_app_number] => 16/180939
[patent_app_country] => US
[patent_app_date] => 2018-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16180939
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/180939 | SILK PROTEIN FRAGMENT COMPOSITIONS AND ARTICLES MANUFACTURED THEREFROM | Nov 4, 2018 | Abandoned |
Array
(
[id] => 14338877
[patent_doc_number] => 20190151411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING CHRONIC LUNG DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/127988
[patent_app_country] => US
[patent_app_date] => 2018-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16127988
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/127988 | METHODS AND COMPOSITIONS FOR TREATING CHRONIC LUNG DISEASES | Sep 10, 2018 | Abandoned |
Array
(
[id] => 16512945
[patent_doc_number] => 20200392203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => IMMUNOTHERAPY AGAINST TRANSFERRIN RECEPTOR 1 (TFR1)-TROPIC ARENAVIRUSES
[patent_app_type] => utility
[patent_app_number] => 16/638816
[patent_app_country] => US
[patent_app_date] => 2018-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638816
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638816 | IMMUNOTHERAPY AGAINST TRANSFERRIN RECEPTOR 1 (TFR1)-TROPIC ARENAVIRUSES | Aug 13, 2018 | Abandoned |
Array
(
[id] => 14277149
[patent_doc_number] => 20190135859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => METHOD OF MANUFACTURING A PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/100802
[patent_app_country] => US
[patent_app_date] => 2018-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16100802
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/100802 | METHOD OF MANUFACTURING A PHARMACEUTICAL COMPOSITION | Aug 9, 2018 | Abandoned |
Array
(
[id] => 18962965
[patent_doc_number] => 11896704
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes
[patent_app_type] => utility
[patent_app_number] => 16/628594
[patent_app_country] => US
[patent_app_date] => 2018-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31033
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16628594
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/628594 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | Jun 4, 2018 | Issued |
Array
(
[id] => 13424895
[patent_doc_number] => 20180263990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY
[patent_app_type] => utility
[patent_app_number] => 15/985861
[patent_app_country] => US
[patent_app_date] => 2018-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15985861
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/985861 | CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY | May 21, 2018 | Abandoned |
Array
(
[id] => 13457879
[patent_doc_number] => 20180280482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => COMPOSITIONS AND METHODS FOR MODULATING TOLL-LIKE RECEPTOR 2 ACTIVATION
[patent_app_type] => utility
[patent_app_number] => 15/969197
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15969197
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/969197 | Compositions and methods for modulating toll-like receptor 2 activation | May 1, 2018 | Issued |
Array
(
[id] => 13368715
[patent_doc_number] => 20180235898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => ENZYME RESPONSIVE NANOCAPSULES FOR PROTEIN DELIVERY
[patent_app_type] => utility
[patent_app_number] => 15/961407
[patent_app_country] => US
[patent_app_date] => 2018-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15961407
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/961407 | ENZYME RESPONSIVE NANOCAPSULES FOR PROTEIN DELIVERY | Apr 23, 2018 | Abandoned |
Array
(
[id] => 16389614
[patent_doc_number] => 20200330555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => METHODS OF TREATING GASTROINTESTINAL MOTILITY-RELATED DISORDERS USING VARIANTS AND FUSIONS OF FGF19/FGF21 POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/606455
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606455
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606455 | METHODS OF TREATING GASTROINTESTINAL MOTILITY-RELATED DISORDERS USING VARIANTS AND FUSIONS OF FGF19/FGF21 POLYPEPTIDES | Apr 19, 2018 | Abandoned |
Array
(
[id] => 18642427
[patent_doc_number] => 11766480
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Multivalent peptoid oligomers, pharmaceutical compositions and methods of using same
[patent_app_type] => utility
[patent_app_number] => 15/938418
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 20534
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15938418
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/938418 | Multivalent peptoid oligomers, pharmaceutical compositions and methods of using same | Mar 27, 2018 | Issued |
Array
(
[id] => 13444115
[patent_doc_number] => 20180273600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => INSULIN SECRETING POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 15/933079
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15933079
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/933079 | Insulin secreting polypeptides | Mar 21, 2018 | Issued |
Array
(
[id] => 18412109
[patent_doc_number] => 11666636
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => GLP-1R agonists and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/485190
[patent_app_country] => US
[patent_app_date] => 2018-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 17
[patent_no_of_words] => 17213
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485190
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485190 | GLP-1R agonists and uses thereof | Feb 13, 2018 | Issued |
Array
(
[id] => 15289225
[patent_doc_number] => 20190387748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE
[patent_app_type] => utility
[patent_app_number] => 16/480142
[patent_app_country] => US
[patent_app_date] => 2018-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480142 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | Jan 23, 2018 | Abandoned |
Array
(
[id] => 14390823
[patent_doc_number] => 10308681
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-04
[patent_title] => Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
[patent_app_type] => utility
[patent_app_number] => 15/856926
[patent_app_country] => US
[patent_app_date] => 2017-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9387
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15856926
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/856926 | Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient | Dec 27, 2017 | Issued |
Array
(
[id] => 12862243
[patent_doc_number] => 20180179255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => HEPARIN-BINDING CATIONIC PEPTIDE SELF-ASSEMBLING PEPTIDE AMPHIPHILES USEFUL AGAINST DRUG-RESISTANT BACTERIA
[patent_app_type] => utility
[patent_app_number] => 15/832194
[patent_app_country] => US
[patent_app_date] => 2017-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14372
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15832194
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/832194 | Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria | Dec 4, 2017 | Issued |
Array
(
[id] => 14990971
[patent_doc_number] => 20190314443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => COMPOSITION FOR SUPPRESSING MUSCULAR ATROPHY
[patent_app_type] => utility
[patent_app_number] => 16/466488
[patent_app_country] => US
[patent_app_date] => 2017-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16466488
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/466488 | Composition for suppressing muscular atrophy | Dec 3, 2017 | Issued |
Array
(
[id] => 15681355
[patent_doc_number] => 20200095341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => FUNCTIONALIZATION OF BIOPOLYMERS WITH GROWTH FACTOR-BINDING PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/465524
[patent_app_country] => US
[patent_app_date] => 2017-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16465524
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/465524 | Functionalization of biopolymers with growth factor-binding peptides | Nov 29, 2017 | Issued |
Array
(
[id] => 13537227
[patent_doc_number] => 20180320160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
[patent_app_type] => utility
[patent_app_number] => 15/820265
[patent_app_country] => US
[patent_app_date] => 2017-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15820265
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/820265 | LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE | Nov 20, 2017 | Abandoned |
Array
(
[id] => 13354385
[patent_doc_number] => 20180228732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => SUSTAINED-RELEASE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 15/809459
[patent_app_country] => US
[patent_app_date] => 2017-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21686
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15809459
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/809459 | SUSTAINED-RELEASE FORMULATION | Nov 9, 2017 | Abandoned |